We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Jersey OTC Drugmaker Hit for Quality Unit Shortcomings
New Jersey OTC Drugmaker Hit for Quality Unit Shortcomings
Over-the-counter drugmaker US Pharmaceuticals of Belleville, N.J. drew a Form 483 from the FDA with four observations following an Oct. 6-16, 2020 inspection.